Who backs Arialys Therapeutics?
6 investors| Investor | Type |
|---|---|
| Alexandria Venture Investments | Other |
| Johnson & Johnson JJDC | Venture capital |
| MPM BioImpact | Venture capital |
| Alexandria Real Estate Equities | — |
| Avalon Bioventures | — |
| Catalys Pacific | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Arialys Therapeutics investors
6 investors are on record for Arialys Therapeutics, including Alexandria Venture Investments, Johnson & Johnson JJDC, MPM BioImpact and Alexandria Real Estate Equities. The early-stage round in Jun 2025 drew 7 investors.
Free account
More of Arialys Therapeutics with a free account
- ·Watch Arialys Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 6 firms already write checks for companies like Arialys Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View